| http://www.w3.org/ns/prov#value | - But some FDA scientists said that the study was unreliable because it underreported heart attacks and other problems.Ultimately, the agency decided to severely limit which patients could take the drug, concluding that the potential risks of heart attack and stroke outweighed the drug's benefits.Currently U.S. patients can only receive Avandia after signing a waiver from their doctor indicating tha
|
